futuuropen

Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?

Name: Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?
Creator: Forecast Insight

OUI

—

NON

—

Fournisseur: Alzheimer's disease

Liquidity: $246.68

mis à jour: Mar 14, 2026, 06:01 AM

Commentaires (0)

Connectez-vous pour commenter. Connexion

Aucun résultat